Source: TraceLink

TraceLink to Discuss Global Serialisation Strategies at CPhI Worldwide

NORTH READING, MA--(Marketwired - Sep 26, 2016) -  TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, will be addressing delegates at CPhI Worldwide, the annual pharmaceutical congress taking place October 4 - 6, in Barcelona, Spain. TraceLink will be partnering with its customer, Sharp Packaging Services, to display its proven Life Sciences Cloud solution in the Sharp CPhI booth in Hall 3, Stand L56.

On the first day of the meeting, Jean-Marie Aulnette, vice president of EMEA, TraceLink, will discuss "Key success factors for achieving compliance and ensuring supply when implementing a global serialisation strategy." The presentation, which takes place in the Pharma Insight Briefing room on Tuesday, October 4 at 12:30 p.m. CEST, will explore how to:

  • Achieve global compliance with multiple country regulations;
  • Manage data management challenges;
  • Orchestrate CMO network on-boarding;
  • Ensure line management readiness and integration.

Also at the CPhI Congress, TraceLink will be honored as a finalist for the Pharma Awards 2016 in the "Excellence in Pharma: Regulatory Procedures and Compliance" category. Winners will be announced at the CPhI awards gala on the evening of October 4.

With offices in the UK, India, Singapore and the United States, 69 percent of TraceLink's pharmaceutical and contract manufacturing customers have compliance requirements for the EU (EU Falsified Medicine Directive), India, Brazil, China, South Korea, Turkey, Argentina, Russia and Saudi Arabia.

At this year's CPhI meeting, schedule a free onsite serialisation consultation with a TraceLink compliance expert and receive custom guidance on how to move your company's serialization strategy forward.

About TraceLink
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations.

A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost.

For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.

TraceLink is funded by FirstMark Capital, Volition Capital and F-Prime Capital.

Contact Information:

Media Contact:

Aimee Genzler
Director, Corporate Communications

978.396.6150